135 related articles for article (PubMed ID: 38092300)
1. Integration of proteomics and metabolomics reveals energy and metabolic alterations induced by glucokinase (GCK) partial inactivation in hepatocytes.
Xie Z; Liu J; Xie T; Liu P; Hui X; Zhang Q; Xiao X
Cell Signal; 2024 Feb; 114():111009. PubMed ID: 38092300
[TBL] [Abstract][Full Text] [Related]
2. Glucokinase Inactivation Ameliorates Lipid Accumulation and Exerts Favorable Effects on Lipid Metabolism in Hepatocytes.
Xie Z; Xie T; Liu J; Zhang Q; Xiao X
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901746
[TBL] [Abstract][Full Text] [Related]
3. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
4. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
5. Functional Inactivation of
Mascolo E; Liguori F; Stufera Mecarelli L; Amoroso N; Merigliano C; Amadio S; Volonté C; Contestabile R; Tramonti A; Vernì F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477627
[TBL] [Abstract][Full Text] [Related]
6. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.
Arden C; Petrie JL; Tudhope SJ; Al-Oanzi Z; Claydon AJ; Beynon RJ; Towle HC; Agius L
Diabetes; 2011 Dec; 60(12):3110-20. PubMed ID: 22013014
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
8. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
[TBL] [Abstract][Full Text] [Related]
9. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
10. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
12. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
Gutierrez-Nogués A; García-Herrero CM; Oriola J; Vincent O; Navas MA
Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2385-2394. PubMed ID: 29704611
[TBL] [Abstract][Full Text] [Related]
14. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
15. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice.
Wang R; Gao H; Xu W; Li H; Mao Y; Wang Y; Guo T; Wang X; Song R; Li Z; Irwin DM; Niu G; Tan H
Gene; 2013 Mar; 516(2):248-54. PubMed ID: 23291412
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of the glucokinase impaired function - GCK MODY today.
Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
Al-Oanzi ZH; Fountana S; Moonira T; Tudhope SJ; Petrie JL; Alshawi A; Patman G; Arden C; Reeves HL; Agius L
Diabetes Obes Metab; 2017 Aug; 19(8):1078-1087. PubMed ID: 28206714
[TBL] [Abstract][Full Text] [Related]
19. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
[TBL] [Abstract][Full Text] [Related]
20. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
